RE:RE:RE:RE:RE:Keep patient, maybe we are at last step to the final victoryPlantrader: Thank you for your balanced views. Yes, being a small company with limited funding creates problems. They've done a lot with what they were given. However, keeping shareholders interested (and motivated to keep holding) could use a little more work. Just tell us where things are at in a more transparent way. Don't bury delays under NRs that have different subject headers, like expanding your clinical team. Id be happy if they just communicated better.
plantrader wrote: Basic psychology. Everyone is hopeful, but the company is at risk of running out of money several times per year at this point, right? Is that debatable? The clinical data that we're aware of is very promising. There are lots of great possibilities. However, nothing seems to happen even remotely close to the timelines the company shoots for. And the info or explanations offered to help shareholders understand along the way regarding why things changed, or why goals haven't been realized yet, appear to be thin if not sometimes non-existent. Right? I'm sure some of that is due to the FDA, and I'm sure some of that is due to the company being small, not enough money and/or staff (same thing) and maybe they don't want to look bad via airing all dirty laundry along the way?
Surely the company is not blameless for how things have gone (right or wrong), but at the same time despite it being many years they have still made some impressive progress or accomplishments. So, it's a confusing mixed bag with little thus far in the way of recent FDA-recognized progress as far as the things that will help the treatment come to market. Right? This confusing mix of factors has folks on edge and some default to the old tired basher vs pumper schtick. They are afraid that words will mean something and influence others, while holding on by a thread all the while. Blaming other individuals is sometimes easier than being fully objective or feeling guilty for pointing to the company itself after loading up on shares and putting ones belief and trust into it. IMO it's a basic fact that not all factors are great at this time (funding, whatever), and I'm sure a case can be made for both hanging in there or loading up at low prices as well as bailing due to lack of recent official accomplishments. IMO a partnership of some sort, which might come with some assistance in coordinating / running / managing everything might be best at this point IMO. It's not easy for a small or startup co to go it alone these days, right? Without $ and/or big names helping push, I have a feeling that MOST management would end up looking bad somehow in some way over the course of so many years. Even if they are well meaning and forthright and trying to serve the best interest of everyone including shareholders.